Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01074437 · ClinicalTrials.gov registry record · Phase 2
Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)
A Phase 2 study, sponsored by Seattle Children's Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT01074437: Clinical Trial Phase 2 study, sponsored by Seattle Children's Hospital.
NCT01074437 is a Phase 2 study that was terminated before completion, run by Seattle Children's Hospital. The registered enrollment target is 9 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01074437, a Phase 2 study, was terminated before completion, sponsored by Seattle Children's Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a prospective randomized, double-blind study to compare the clinical efficacy of infantile hemangioma treatment using propranolol with corticosteroids as compared to therapy with corticosteroids and placebo. We hypothesize that a two-month treatment period with propranolol plus corticosteroids is more effective at reducing infantile hemangioma size and vascularity when compared to corticosteroids used without propranolol for the same time period.
Primary Outcome
This outcome cannot be evaluated. Trial limited by lack of patient family to have randomization, which limited the number of participants and made the project nonviable.
Interventions
- DRUG Placebo
- DRUG Propranolol
- DRUG Prednisolone (Corticosteroid)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-02 |
| Phase | Phase 2 |
Why NCT01074437 stopped before completion
NCT01074437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01074437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01074437 about?
NCT01074437 is a clinical study titled "Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)". This is a prospective randomized, double-blind study to compare the clinical efficacy of infantile hemangioma treatment using propranolol with corticosteroids as compared to therapy with corticosteroids and placebo. We hypothesize that a two-month treatment period with propranolol plus corticosteroi...
What is the current status of trial NCT01074437?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2010-02. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01074437?
The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG), Prednisolone (Corticosteroid) (DRUG).
Who is sponsoring clinical trial NCT01074437?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01074437's enrollment target sits among peer trials
9 1989th of 2000 higher than 11 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia